Jing Wang
46Patents
1h-index
222Co-inventors
56Inventor score
Filing activity: Nov 17, 2006 → Jun 27, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11779572B1 | Methods of treating gastrointestinal stromal tumors | Human Necessities | 12 | Active |
| US10717720B2 | Modified compound of andrographolide | Chemistry; Metallurgy | 1 | Active |
| US11053260B2 | Tri-cycle compound and applications thereof | Chemistry; Metallurgy | 1 | Active |
| US9593151B2 | Use of fusion protein | Chemistry; Metallurgy | 1 | Active |
| US10900966B2 | Use of glycan as biomarkers for autoimmune diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US11491173B2 | Pharmaceutical composition and application thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US9974321B2 | Fish protein oligopeptide with low allergenicity and slight fishiness and industrial preparation method and application thereof | Human Necessities | 0 | Active |
| US12037627B2 | Lactobacillus paracasei and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10537601B2 | Method of isolating anti-viral ingredients from Baphicacanthus cusia, compositions comprising them and their medical use | Human Necessities | 0 | Active |
| US9624162B2 | Method for preparing 3-aminomethyl-3,5,5-trimethyl cyclohexylamine | Chemistry; Metallurgy | 0 | Active |
| US11667901B2 | Chondrosulphatase and use thereof | Chemistry; Metallurgy | 0 | Active |
| US10674723B2 | 1,8-bis(Schiff base)-p-menthane derivatives as well as preparation method and applications thereof | Physics | 0 | Active |
| US11834716B2 | Method for predicting response of esophagus cancer to anti-ERBB3 antibody therapy, and kit | Physics | 0 | Active |
| US11357806B2 | Method of isolating sphingolipids from cordyceps and their use | Physics | 0 | Active |
| US11952388B2 | Crystal form of tri-cycle compound and application thereof | Chemistry; Metallurgy | 0 | Active |
| US12065378B2 | Method for preparing low-background cement | Emerging Cross-Sectional Technologies | 0 | Active |
| US12150944B2 | Use of anti-HER2 antibody-drug conjugate in cancer treatment | Human Necessities | 0 | Active |
| US10234454B2 | Use of glycan as biomarkers for autoimmune diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US12343448B2 | Use of stem cells produced by stem cell generator in treatment of hematopoietic damage | Human Necessities | 0 | Active |
| US10278966B2 | Method of isolating quaternary phenanthroindolizidine alkaloids with G-quaduplex DNA binding activity from Tylophra atrofolliculata, compositions comprising them and their medical use | Human Necessities | 0 | Active |
| US11293906B2 | Method for judgment of cheddar grade based on identification characteristic flavor composition | Physics | 0 | Active |
| US12252555B2 | Selenium-chelating pea oligopeptide, and preparation method and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11712042B2 | High esters producing strain of Monascus purpureus and its application in production of ester flavor Monascus fermented cheese | Chemistry; Metallurgy | 0 | Active |
| US10039797B2 | Methods of identifying and quantifying sphingolipids | Physics | 0 | Active |
| US11111248B2 | Crystal form of 2-(6-methyl-pyridin-2-yl)-3-yl-[6-amido-quinolin-4-yl]-5,6-dihydro-4H-pyrrolo[1,2-B]pyrazole, preparation method therefor and pharmaceutical composition thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.